☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Fda approval
AstraZeneca and the US NIAID Report Results of Fasenra (benralizumab) in P-II Study for Hypereosinophilic Syndromes (HES)
April 4, 2019
Clarus Therapeutics' Jatenzo (Testosterone Undecanoate Capsules for Oral Use) (CIII) Receives FDA'S Approval for Testosterone Repl...
March 27, 2019
Roche's Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) Receives FDA's Approval for Patients with HER2-Positive Breast Canc...
March 1, 2019
Teva's ProAir Digihaler (Albuterol Sulfate 117 mcg) Inhalation Powder Receives FDA Approval for Asthma & COPD Patients Aged 4...
December 31, 2018
Merck's Keytruda (pembrolizumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma (HCC)
November 12, 2018
AstraZeneca's Lumoxiti Receives FDA approval for the Treatment of R/R 2L+ Hairy Cell Leukemia in patients
September 14, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.